Clinical Trial to Investigate the Pharmacokinetics and Safety of CKD-393

Clinical trial NCT04706286 · UNKNOWN

Trial details

NCT number: NCT04706286
Sponsor: Chong Kun Dang Pharmaceutical
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

T2DM (Type 2 Diabetes Mellitus)

Start date: 2021-02-18
Primary completion: 2021-03-29
Enrollment: 26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.